Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $17.08B (99.6% shares, 0.4% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | 30,743,991 | $3.037B | 17.8% | $72.80 | +32.9% | COM | 45337C102 |
| ONC | BeOne Medicines Ltd. | 8,799,053 | $2.673B | 15.7% | $136.93 | — | SPONSORED ADS | 07725L102 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 2,141,701 | $1.247B | 7.3% | $139.37 | +266.5% | COM | 558868105 |
| INSM | Insmed Incorporated | 6,592,746 | $1.147B | 6.7% | $57.51 | +217.3% | COM PAR $.01 | 457669307 |
| ACAD | ACADIA Pharmaceuticals Inc. | 42,896,690 | $1.146B | 6.7% | $18.93 | +26.2% | COM | 004225108 |
| CELC | Celcuity Inc. | 7,915,792 | $790M | 4.6% | $21.19 | +287.9% | COM | 15102K100 |
| RVMD | Revolution Medicines, Inc. | 9,455,357 | $753M | 4.4% | $29.36 | +123.4% | COM | 76155X100 |
| KYMR | Kymera Therapeutics, Inc. | 8,657,242 | $674M | 3.9% | $37.74 | +78.9% | COM | 501575104 |
| SMMT | Summit Therapeutics Inc. | 36,391,063 | $636M | 3.7% | $11.11 | +69.3% | COM | 86627T108 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 5,604,483 | $600M | 3.5% | $23.49 | +351.7% | COM | 76243J105 |
| KOD | Kodiak Sciences Inc. | 19,919,186 | $557M | 3.3% | $29.02 | -29.4% | COM | 50015M109 |
| PRAX | Praxis Precision Medicines, Inc. | 1,126,488 | $332M | 1.9% | $99.31 | +87.5% | COM | 74006W207 |
| ALKS | Alkermes plc | 10,012,267 | $280M | 1.6% | $27.44 | +9.2% | SHS | G01767105 |
| GRAL | GRAIL, Inc. | 2,085,333 | $178M | 1.0% | $31.57 | +173.7% | COM | 384747101 |
| EWTX | Edgewise Therapeutics, Inc. | 6,575,940 | $163M | 1.0% | $14.29 | +40.4% | COM | 28036F105 |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 2,175,645 | $144M | 0.8% | $24.96 | +96.4% | COM | 04280A100 |
| IONS | Ionis Pharmaceuticals, Inc. | 1,791,841 | $142M | 0.8% | $66.92 | +12.5% | COM | 462222100 |
| IMVT | Immunovant, Inc. | 5,457,881 | $139M | 0.8% | $22.96 | -2.9% | COM | 45258J102 |
| IMTX | Immatics N.V. | 12,094,094 | $127M | 0.7% | $8.55 | +18.0% | SHS | N44445109 |
| IDYA | IDEAYA Biosciences, Inc. | 3,618,826 | $125M | 0.7% | $20.65 | +54.4% | COM | 45166A102 |
| ROIV | Roivant Sciences Ltd. | 5,555,017 | $121M | 0.7% | $12.94 | +52.5% | SHS | G76279101 |
| ABVX | Abivax S.A. | 875,796 | $118M | 0.7% | $84.90 | — | SPONSORED ADS | 00370M103 |
| KNSA | Kiniksa Pharmaceuticals International, plc | 2,826,246 | $117M | 0.7% | $18.73 | +114.1% | ORD SHS CL A | G52694109 |
| REPL | Replimune Group, Inc. | 11,045,336 | $107M | 0.6% | $14.45 | -41.2% | COM | 76029N106 |
| STOK | Stoke Therapeutics, Inc. | 3,336,697 | $106M | 0.6% | $9.30 | +223.1% | COM | 86150R107 |
| GPCR | Structure Therapeutics Inc. | 1,432,529 | $99.63M | 0.6% | $22.23 | — | SPONSORED ADS | 86366E106 |
| ABCL | AbCellera Biologics Inc. | 27,525,640 | $94.14M | 0.6% | $21.02 | -78.8% | COM | 00288U106 |
| NRIX | Nurix Therapeutics, Inc. | 4,658,556 | $88.37M | 0.5% | $20.95 | -31.4% | COM | 67080M103 |
| IMCR | Immunocore Holdings plc | 2,322,656 | $80.62M | 0.5% | $38.09 | — | ADS | 45258D105 |
| BCYC | Bicycle Therapeutics plc | 10,885,357 | $77.07M | 0.5% | $20.78 | — | SPONSORED ADS | 088786108 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 1,648,869 | $76.75M | 0.4% | $42.20 | +5.5% | COM | 22663K107 |
| GLUE | Monte Rosa Therapeutics, Inc. | 4,345,736 | $68.14M | 0.4% | $6.49 | +107.5% | COM | 61225M102 |
| — | Celcuity Inc. | 30,750,000 | $66.58M | 0.4% | $1.33 | — | Note 2.75% 8/1/2031 | 15102KAA8 |
| RARE | Ultragenyx Pharmaceutical Inc. | 2,772,692 | $63.77M | 0.4% | $52.13 | -36.9% | COM | 90400D108 |
| DNLI | Denali Therapeutics Inc. | 3,731,695 | $61.61M | 0.4% | $23.78 | -29.0% | COM | 24823R105 |
| VRDN | Viridian Therapeutics, Inc. | 1,971,678 | $61.36M | 0.4% | $15.17 | +80.8% | COM | 92790C104 |
| TRDA | Entrada Therapeutics, Inc. | 5,072,730 | $52.15M | 0.3% | $16.68 | — | COM | 29384C108 |
| RAPP | Rapport Therapeutics, Inc. | 1,547,090 | $46.94M | 0.3% | $15.27 | +81.3% | COM | 75383L102 |
| TERN | Terns Pharmaceuticals, Inc. | 950,000 | $38.38M | 0.2% | $23.11 | 0.0% | COM | 880881107 |
| BNTX | BioNTech SE | 368,923 | $35.12M | 0.2% | $107.38 | — | SPONSORED ADS | 09075V102 |
| SYRE | Spyre Therapeutics, Inc. | 1,000,000 | $32.76M | 0.2% | $15.36 | +70.1% | COM | 00773J202 |
| DNTH | Dianthus Therapeutics, Inc. | 789,759 | $32.55M | 0.2% | $18.76 | +106.7% | COM | 252828108 |
| PRLD | Prelude Therapeutics Inc. | 10,123,824 | $29.36M | 0.2% | $28.24 | -94.0% | COM | 74065P101 |
| DBVT | DBV Technologies S.A. | 1,461,425 | $28.02M | 0.2% | $3.09 | — | SPONSORED ADS | 23306J309 |
| IRON | Disc Medicine, Inc. | 337,050 | $26.77M | 0.2% | $49.46 | +70.9% | COM | 254604101 |
| JBIO | Jade Biosciences, Inc. | 1,641,137 | $25.32M | 0.1% | $11.73 | 0.0% | COM | 008064206 |
| TSHA | Taysha Gene Therapies, Inc. | 4,004,756 | $22.03M | 0.1% | $1.91 | +153.6% | COM SHS | 877619106 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 2,822,727 | $22.02M | 0.1% | $7.23 | 0.0% | COM | 09058V103 |
| VTYX | Ventyx Biosciences, Inc. | 2,349,280 | $21.21M | 0.1% | $5.37 | +39.1% | COM | 92332V107 |
| ARGX | argenx SE | 25,174 | $21.17M | 0.1% | $79.01 | — | SPONSORED ADR | 04016X101 |
| DSGN | Design Therapeutics, Inc. | 2,233,099 | $20.95M | 0.1% | $11.07 | -29.3% | COM | 25056L103 |
| CERS | Cerus Corporation | 10,008,345 | $20.62M | 0.1% | $4.19 | -58.6% | COM | 157085101 |
| NGNE | Neurogene Inc. | 991,691 | $20.43M | 0.1% | $19.35 | +28.6% | COM | 64135M105 |
| TECX | Tectonic Therapeutic, Inc. | 903,400 | $18.84M | 0.1% | $20.13 | -7.7% | COM | 878972108 |
| CTMX | CytomX Therapeutics, Inc. | 4,250,826 | $18.11M | 0.1% | $1.73 | +119.9% | COM | 23284F105 |
| CLDX | Celldex Therapeutics, Inc. | 665,370 | $18.07M | 0.1% | $23.17 | +13.7% | COM | 15117B202 |
| XNCR | Xencor, Inc. | 1,102,106 | $16.87M | 0.1% | $16.65 | -10.2% | COM | 98401F105 |
| CNTA | Centessa Pharmaceuticals plc | 670,751 | $16.78M | 0.1% | $25.01 | — | SPONSORED ADS | 152309100 |
| XENE | Xenon Pharmaceuticals Inc. | 370,208 | $16.59M | 0.1% | $19.37 | +116.8% | COM | 98420N105 |
| SION | Sionna Therapeutics, Inc. | 400,000 | $16.46M | 0.1% | $16.34 | +132.1% | COM | 829401108 |
| CTNM | Contineum Therapeutics, Inc. | 1,420,838 | $16.24M | 0.1% | $11.67 | -2.2% | CL A | 21217B100 |
| SERA | Sera Prognostics, Inc. | 5,498,170 | $16.22M | 0.1% | $3.09 | +4.2% | CLASS A COM | 81749D107 |
| DYN | Dyne Therapeutics, Inc. | 813,449 | $15.91M | 0.1% | $18.94 | 0.0% | COM | 26818M108 |
| ALMS | Alumis Inc. | 1,562,500 | $15.25M | 0.1% | $13.30 | -47.5% | COM | 022307102 |
| NUVL | Nuvalent, Inc. | 143,937 | $14.48M | 0.1% | $73.17 | +34.8% | COM | 670703107 |
| PHVS | Pharvaris N.V. | 375,000 | $10.41M | 0.1% | $22.18 | +8.6% | COM | N69605108 |
| RLAY | Relay Therapeutics, Inc. | 1,160,117 | $9.815M | 0.1% | $13.78 | -48.2% | COM | 75943R102 |
| ABSI | Absci Corporation | 2,134,803 | $7.45M | 0.0% | $3.64 | 0.0% | COM | 00091E109 |
| RCUS | Arcus Biosciences, Inc. | 270,000 | $6.434M | 0.0% | $20.40 | 0.0% | COM | 03969F109 |
| MPLT | MapLight Therapeutics, Inc. | 364,705 | $6.406M | 0.0% | $16.75 | 0.0% | COM | 56565P103 |
| VTVT | vTv Therapeutics, Inc. | 148,314 | $5.931M | 0.0% | $14.29 | +94.0% | CL A | 918385204 |
| WVE | Wave Life Sciences Ltd. | 344,063 | $5.849M | 0.0% | $5.98 | +70.0% | SHS | Y95308105 |
| SGMT | Sagimet Biosciences Inc. | 952,996 | $5.642M | 0.0% | $9.53 | -24.6% | COM SER A | 786700104 |
| TARA | Protara Therapeutics, Inc. | 971,614 | $5.179M | 0.0% | $9.86 | -43.6% | COM STK | 74365U107 |
| LBRX | LB Pharmaceuticals Inc. | 200,000 | $4.452M | 0.0% | $15.87 | +10.1% | COM SHS | 50180M108 |
| ELVN | Enliven Therapeutics, Inc. | 271,406 | $4.18M | 0.0% | $17.98 | +10.8% | COM | 29337E102 |
| FDMT | 4D Molecular Therapeutics, Inc. | 475,737 | $3.568M | 0.0% | $10.14 | 0.0% | COM | 35104E100 |
| VIR | Vir Biotechnology, Inc. | 542,539 | $3.272M | 0.0% | $7.89 | -24.5% | COM | 92764N102 |
| TCRX | TScan Therapeutics, Inc. | 2,784,792 | $2.785M | 0.0% | $6.08 | -76.2% | COM | 89854M101 |
| SANA | Sana Biotechnology, Inc. | 310,483 | $1.264M | 0.0% | $4.55 | -1.7% | COM | 799566104 |
| SKYE | Skye Bioscience, Inc. | 1,450,638 | $1.088M | 0.0% | $7.74 | -81.1% | COM | 83086J200 |
| KALA | KALA BIO, Inc. | 1,804,055 | $1.003M | 0.0% | $4.62 | -80.6% | COM | 483119202 |
| ALGS | Aligos Therapeutics, Inc. | 83,055 | $774K | 0.0% | $12.44 | -24.2% | COM | 01626L204 |
| TYRA | Tyra Biosciences, Inc. | 10,607 | $279K | 0.0% | $12.95 | +41.9% | COM | 90240B106 |
| ACRV | Acrivon Therapeutics, Inc. | 22,809 | $54,970 | 0.0% | $4.64 | -53.2% | COMMON STOCK | 004890109 |
| SRZNW | Surrozen, Inc. | 833,333 | $16,667 | 0.0% | $1.14 | — | W EXP 8/11/2026 | 86889P117 |